Top Markets
Coin of the day
EirGenix Inc. EirGenix Inc.

EirGenix Inc.

6589
Rank in Stocks #14111
EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions... EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions as a contract development and manufacturing organization (CDMO) with operations spanning both domestic and international markets. The company offers a comprehensive range of services, encompassing cell line creation, process optimization, analytical testing and quality control, and current Good Manufacturing Practice (cGMP) compliant production utilizing both mammalian and microbial expression systems. They also specialize in services related to antibody-drug conjugates (ADCs). Beyond its service offerings, EirGenix is actively engaged in developing several therapeutic candidates. This pipeline includes EG12014/EGI014, a Trastuzumab biosimilar intended for cancer therapy, which has reached the biologics license application (BLA) submission stage. Other oncology-focused developments are EG1206A, a Pertuzumab biosimilar currently in Phase I clinical trials; EG13074, in preclinical development; and TSY0110(EG12043), an antibody-drug conjugate also in preclinical stages. Additionally, the company is advancing EG12021, a Bevacizumab biosimilar for cancer treatment, and EG62054, another biosimilar, both in preclinical development. In addition to its core activities, EirGenix manufactures and distributes a rapid antigen test for COVID-19, as well as the CRM197 carrier protein under the designation EG74032.
Share Price
$1.46
Last synced: 2026-07-28
Market Cap
$435.25M
Change (1 day)
-2.34%
Change (1 year)
-25.65%
Country
TW
Trade EirGenix Inc. (6589)

Category

Stock price history for EirGenix Inc. (6589)
Highest end of day price: $1.51 on 2026-07-01

Lowest end of day price: $1.20 on 2016-11-01
Stock price history of EirGenix Inc. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -13.78%
2025 -9.30%
2024 -26.56%
2023 -26.09%
2022 8.79%
2021 147.12%
2020 94.40%
2019 -9.39%
2018 16.53%
2017 -30.22%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.43 -11.16%
AU
$138.80 476.17%
US
$749.90 5.10%
CH